Stock listing

NASDAQ:FVAM 5 01 Acquisition Corp Stock

Follow 5 01 Acquisition Corp into a list and get an email when it puts out news.

Last close · NASDAQ:FVAM

$10.00 USD

Close on Oct 26, 2022 · No longer trades

Oct 14, 2020 to last close 0.0% · weekly closes, Oct 14, 2020 – Oct 26, 2022
Lowest – highest close
$9.72 – $11.50 USDSince Oct 14, 2020 · lowest Aug 4, 2021 · highest Feb 22, 2021

Delisted NASDAQ:FVAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FVAM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kush M. Parmar
Other companies: Entrada Therapeutics, Inc. (Managing Partner, 5am Ventures (Board Chairman) · Since at least Oct 28, 2021); Rallybio Corporation (Director · Jul 28, 2021 – May 15, 2024 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – Jun 14, 2022 · Past); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Arvinas, Inc. (Director · Sep 26, 2018 – Sep 24, 2019 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 15, 2022 · Past); Scpharmaceuticals Inc (Director · Nov 16, 2017 – Jun 19, 2018 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jun 8, 2018 · Past)
Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past
Martin Mackay
Other companies: Kailera Therapeutics, Inc. (Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026); SpringWorks Therapeutics Inc (Director · Since at least Jul 29, 2024); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); Alexion Pharmaceuticals Inc (EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past)
Director · Oct 13, 2020 – Oct 16, 2020 · Past
Andrew J Schwab
Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Skye Bioscience, Inc. (Director · Since at least Aug 18, 2023); Enliven Therapeutics, Inc. (Director · Feb 23, 2023 – Feb 23, 2023 · Past); Pear Therapeutics Inc (Director · Dec 3, 2021 – Dec 3, 2021 · Past); Flexion Therapeutics Inc (Director · Feb 11, 2014 – Mar 3, 2014 · Past)
Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past
Daniella Beckman
Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Blueprint Medicines Corp (Director · Since at least Dec 8, 2021); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past)
Director · Oct 13, 2020 – Oct 16, 2020 · Past
Matthew R Patterson
Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past); Audentes Therapeutics Inc (Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past)
Director · Oct 13, 2020 – Oct 16, 2020 · Past
Galya Blachman
Other companies: Enliven Therapeutics, Inc. (Chief Legal Officer and Head of Business Development · Since at least Nov 5, 2026)
GC and Secretary · Oct 13, 2020 – Oct 13, 2020 · Past
Jason R RuthChief Business Officer · Oct 13, 2020 – Oct 13, 2020 · Past
Rebecca L LuciaCFO and Treasurer · Oct 13, 2020 – Oct 13, 2020 · Past
Samantha L SingerDirector · Nov 16, 2020 – Nov 17, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about 5 01 Acquisition Corp.